Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04149496 · ClinicalTrials.gov registry record · NA
IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer
A NA study of Polycystic Ovary Syndrome, sponsored by Bruce Rose, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT04149496: Recruiting NA study of Polycystic Ovary Syndrome, sponsored by Bruce Rose, MD.
NCT04149496 is a NA study of Polycystic Ovary Syndrome that is actively recruiting participants, run by Bruce Rose, MD. The registered enrollment target is 300 participants, below the 17,248-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04149496, a NA study of Polycystic Ovary Syndrome, is actively recruiting participants, sponsored by Bruce Rose, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
A protocol was developed to improve pregnancy results after IVM compared to results from studies in the literature. Differences from most published protocols include the use of the Steiner-Tan needle to optimize oocyte environment during oocyte retrieval, use of oral medications and very low doses of FSH, and delayed embryo transfer during subsequent warmed cryo-preserved embryo transfer. Eligible patient have a PCO pattern in their ovaries during transvaginal ultrasound.
Primary Outcome
ultrasound evidence of pregnancy in uterus or tissue evidence of pregnancy
Conditions Studied
Interventions
- COMBINATION_PRODUCT in vitro maturation of oocytes
Study Locations (1)
Florida
- Brown Fertility - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What NCT04149496 shows while recruiting
NCT04149496 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 17,248-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which in vitro maturation of oocytes is the first listed.
NCT04149496 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04149496 about?
NCT04149496 is a clinical study titled "IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer". A protocol was developed to improve pregnancy results after IVM compared to results from studies in the literature. Differences from most published protocols include the use of the Steiner-Tan needle to optimize oocyte environment during oocyte retrieval, use of oral medications and very low doses o...
What is the current status of trial NCT04149496?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-05-10. Estimated completion is 2023-12-31.
What conditions does trial NCT04149496 study?
This clinical trial studies the following conditions: Polycystic Ovary Syndrome.
What interventions are being tested in trial NCT04149496?
The interventions under investigation include: in vitro maturation of oocytes (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04149496?
This trial is sponsored by Bruce Rose, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04149496 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Ovary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04149496's enrollment target sits among peer trials
300 4th of 30 higher than 27 of 30 other Polycystic Ovary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Polycystic Ovary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Myo-Inositol for Infertility in PCOS
RECRUITING · NA
-
Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial
ACTIVE NOT RECRUITING · NA
-
A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome
ACTIVE NOT RECRUITING · NA
-
PCOS & Insulin Resistance Exercise Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI